| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 06/08/2004 | US6747158 Anticoagulants |
| 06/08/2004 | US6747132 Methods for the synthesis of a modified hemoglobin solution |
| 06/08/2004 | US6747064 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity |
| 06/08/2004 | US6747040 Imidazonaphthyridines |
| 06/08/2004 | US6747039 Aza-benzothiopyranoindazoles with antitumor activity |
| 06/08/2004 | US6747023 Sulfonyl derivatives |
| 06/08/2004 | US6747002 Determination, calibration erythropoietin dosage; analyzing using computer |
| 06/08/2004 | US6746671 Use of a cytokine-producing lactococcus strain to treat colitis |
| 06/08/2004 | CA2064814C Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 06/03/2004 | WO2004046138A1 Carboxamides |
| 06/03/2004 | WO2004045628A1 Platelet aggregation inhibitor comprising anhydrofructose and its derivative |
| 06/03/2004 | WO2004045599A1 Therapeutic delivery of carbon monoxide |
| 06/03/2004 | WO2004045563A2 Method of treatment of myocardial infarction |
| 06/03/2004 | WO2003086371A3 Use of ep4 receptor ligands in the treatment of il-6 involved diseases |
| 06/03/2004 | WO2003084937A3 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases |
| 06/03/2004 | WO2002102846B1 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 06/03/2004 | US20040107453 Multipotent adult stem cells, sources thereof, methods of obtaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 06/03/2004 | US20040106794 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/03/2004 | US20040106778 Interferon gamma-like protein |
| 06/03/2004 | US20040106730 Polymer complexes of glucuronoglucanes |
| 06/03/2004 | US20040106668 Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin |
| 06/03/2004 | US20040106659 hydantoin, oxazoledione and thiazoledione (or dithiione) derivatives; e.g., 5-[1-(Biphenyl-4-yloxy)-ethyl]-5-methyl-imidazolidine-2,4-dione |
| 06/03/2004 | US20040106656 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/03/2004 | US20040106641 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
| 06/03/2004 | US20040106640 Aryl ether substituted imidazoquinolines |
| 06/03/2004 | US20040106633 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 06/03/2004 | US20040106626 amidine containing compounds which inhibit serine proteases |
| 06/03/2004 | US20040106604 Novel pyrrole derivatives as pharmaceutical agents |
| 06/03/2004 | US20040106558 Hydroxamate-containing cysteine and serine protease inhibitors |
| 06/03/2004 | US20040106155 Method for kidney disease treatment by drug intervention |
| 06/03/2004 | US20040105874 comprising silicone matrix, a hydrophilic carrier, and at least one active agent comprising proteins, particularly enzymes such as hydrolases and glucose oxidase for enzymatic debridement, clotting formation and clot removal and wound healing |
| 06/03/2004 | DE10254336A1 Carbonsäureamide Carboxamides |
| 06/02/2004 | EP1424344A1 Modified cDNA factor VIII and its derivates |
| 06/02/2004 | EP1424335A1 Indole derivatives |
| 06/02/2004 | EP1424334A1 Quinazolinone derivative |
| 06/02/2004 | EP1424326A1 Fused-polycyclic compounds |
| 06/02/2004 | EP1424325A1 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 06/02/2004 | EP1423697A2 Secreted proteins |
| 06/02/2004 | EP1423693A1 Erythropoietin and anti-tumor necrosis factor alpha combination therapy |
| 06/02/2004 | EP1423511A2 Nucleic-acid associated proteins |
| 06/02/2004 | EP1423436A2 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids |
| 06/02/2004 | EP1423429A2 Antibodies against caspase-8, their preparation and use |
| 06/02/2004 | EP1423413A1 Peptidic compounds selectively binding to p-selectin |
| 06/02/2004 | EP1423382A2 Pyrazole-derived kinase inhibitors and uses thereof |
| 06/02/2004 | EP1423380A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 06/02/2004 | EP1423362A1 New mandelic acid derivatives and their use as thrombin inhibitors |
| 06/02/2004 | EP1423357A2 Urea derivatives with antiproteolytic activity |
| 06/02/2004 | EP1423132A2 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 06/02/2004 | EP1423130A1 Antithrombotic compositions comprising low molecular weight heparin and low molecular weight dermatan sulphate |
| 06/02/2004 | EP1423107A2 Fatty alcohol drug conjugates |
| 06/02/2004 | EP1423099A1 A new extended release oral dosage form |
| 06/02/2004 | EP1423098A1 A new extended release oral dosage form |
| 06/02/2004 | EP1423082A2 Plasma protein matrices and methods for their preparation |
| 06/02/2004 | EP1423012A2 Isolation and mobilization of stem cells expressing vegfr-1 |
| 06/02/2004 | EP1423002A1 Use of cross-linked, covalently bound urokinase plasminogen activator (scupa)-urokinase plasminogen activator receptor (supar) complex as a fibrinolytic agent |
| 06/02/2004 | EP1259510B1 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| 06/02/2004 | EP1227824B1 Transplant/implant device and method for its production |
| 06/02/2004 | EP0813598B1 Thrombin preparation |
| 06/02/2004 | CN1501940A Composition and method for inhibiting platelet aggregation |
| 06/02/2004 | CN1501935A Novel cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators |
| 06/02/2004 | CN1501931A Novel tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
| 06/02/2004 | CN1501930A Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepi ne-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists |
| 06/02/2004 | CN1501915A Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 06/02/2004 | CN1501827A Ligands of the alpha-v-beta 6 integrin |
| 06/02/2004 | CN1501812A Antithrombotic agents |
| 06/02/2004 | CN1501806A Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles |
| 06/02/2004 | CN1500805A Preparing process for Eptifibatide |
| 06/02/2004 | CN1500781A Inhibitors of interleukin-1 beta converting enzyme |
| 06/02/2004 | CN1500499A Compound formulation of adjusting, curing or improving blood function |
| 06/02/2004 | CN1500482A Drug for diminishing inflammation and antibiosis |
| 06/02/2004 | CN1152041C C-pyrazoleA receptor agonists |
| 06/02/2004 | CN1152023C Substituted polycyclic aryl and hetero aryl uracils as anticoagulant |
| 06/02/2004 | CN1151833C Capsule for reducing blood-lipid and preventing thrombosis |
| 06/02/2004 | CN1151832C Traditional Chinese medicine composition for treating ischemic cardio-cerebral vascular disease and peripheral vascular disease |
| 06/02/2004 | CN1151826C Resolutive |
| 06/01/2004 | USRE38524 Dipeptide derivatives as growth hormone secretagogues |
| 06/01/2004 | US6743810 Indol-3-yl derivatives |
| 06/01/2004 | US6743807 Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α |
| 06/01/2004 | US6743802 Alkyne-aryl phosphodiesterase-4 inhibitors |
| 06/01/2004 | US6743798 Cardiovascular disorders; vasorelaxation, inhibition of platelet aggregation, decrease in blood pressure; stimulation of soluble guanylate cyclase and an intracellular cgmp increase |
| 06/01/2004 | US6743791 Heterocyclic inhibitors of ERK2 and uses thereof |
| 06/01/2004 | US6743790 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use |
| 06/01/2004 | US6743788 Carbamate and oxamide compounds |
| 06/01/2004 | US6743781 Glycerolipid compounds useful for the transfer of an active substance into a target cell |
| 06/01/2004 | US6743775 Slow release formulations comprising anionic polysaccharide |
| 06/01/2004 | US6743611 For encoding clover yellow vein virus nuclear inclusion-a proteins; proteases; aminopeptidases |
| 06/01/2004 | US6743426 Administering protein c; avoiding bleeding, toxicity and side effects of anticoagulant agents |
| 05/29/2004 | CA2451584A1 Modified cdna factor viii and its derivatives |
| 05/27/2004 | WO2004044229A2 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 7A2 (PDE7a2) |
| 05/27/2004 | WO2004043983A1 4-methyl-2-oxo-2h-1-benzopyran-7yl 5-thio-beta-d-xylopyranoside derivative, method for preparing same and pharmaceutical composition containing same |
| 05/27/2004 | WO2004043503A1 Thrombin-carrying bioabsorbable synthetic nonwoven fabric |
| 05/27/2004 | WO2004043486A1 An acqueous pharmaceutical formulation comprising the thrombin inhibitor melagatran and use of the formulation in the manufacture of a medicament for use by nasal administration in treating thromboembolism |
| 05/27/2004 | WO2004043481A2 Compositions containing peptide copper complexes and metalloproteinase inhibitors, and methods related thereto |
| 05/27/2004 | WO2003081258A3 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs) |
| 05/27/2004 | WO2003073986A3 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 05/27/2004 | WO2003002155B1 Vector encoding human globlin gene and use thereof in treatment of hemoglobinopathies |
| 05/27/2004 | WO2002092827A3 Corona-virus-like particles comprising functionally deleted genomes |
| 05/27/2004 | WO2002085923A3 In vivo incorporation of unnatural amino acids |
| 05/27/2004 | WO1999046281A8 Novel polypeptides and nucleic acids encoding the same |
| 05/27/2004 | US20040102633 For therapy and prophylaxis of chronic obstructive pulmonary disease (COPD), asthma, airway hyper- reactivity, cough; inflammatory diseases such as inflammatory bowel disease, psoriasis, fibrositis, osteoarthritis |